Equal Treatment to Shareholders The Board of Directors arranges the Shareholders’ Meeting in such manners that all shareholders have equal rights. The Board of Directors also provides opportunities to minority shareholders so they can nominate a candidate for the Director position and/or propose an additional item for meeting agenda prior to the meeting. A proxy is made possible as an alternative for shareholders who are unable to attend the meeting to exercise their rights. In addition, the Board of Directors established the guidelines and measures for preventing the spread of COVID-19 infection transmission at the 2021 Annual General Meeting of Shareholders. The objectives were to prevent, control and reduce the spread of COVID-19 infection while still ensuring the equitable treatment of shareholders. Disclosure and Transparency of Information In every calendar year including 2021, the Company disclosed information in accordance with the guidelines given in Section 2.6 on Good Corporate Governance and Code of Ethics. In this connection, information was disclosed through the following channels: 1. The SET • Management’s Discussion & Analysis: MD&A. The information is disclosed quarterly. • Annual Registration Statement Form 56-1 One Report • Quarterly Financial Statements • The Company’s Board of Directors’ resolutions, shareholders’ meeting resolutions, and other information 2. The SEC (e.g., Form 56-1 One Report, Prospectus) 3. The Department of Business Development, Ministry of Commerce (e.g., the Company’s information) 4. The Company’s website (www.thanachart.co.th) the information of the Company and the companies under the Group 5. Press, printing media, and other media (e.g., quarterly operating results, explanation of important issues) 6. Quarterly Analyst Meeting 7. Company Visit / One-on-One Meeting 8. Roadshow / Conference 9. Notification to shareholders by mail Measures for Controlling the Use of Inside Information The Company has established measures aiming at controlling the use of inside information, prohibiting directors, executives, and related parties to use the Company’s inside information for one’s own personal benefit. The summary of the measures is as follows: 1. All internal work units of the Company are required to establish a system for keeping inside information in a safe place, ensuring that the information is properly managed and maintained. 2. The Directors, executives at the managerial level, and the first four executives after the managerial level, as well as the Head of the Accounting or Finance Department are required to: • Submit reports on their shareholdings and positions in various companies as well as reports on the derivatives and future contracts with the Company shares as underlying assets, which are held by themselves, their spouses who lives together as husband or wife and their children who have not yet reached the legal age, on a quarterly basis in line with the requirements imposed by the Capital Market Supervisory Board, with copies to the Chairman of the Board of Directors, the Chairperson of the Audit Committee, and the Company Secretary every time. • Submit reports on any change in their holdings of derivatives and futures contracts with the Company shares as underlying assets, to the SEC within the next three business days after the change in their holdings takes place. 3. The Directors, executives, staff, outsource personnel, and consultants who have access to material inside information which have not yet been disclosed to the public are prohibited from using the information for the benefit of one’s own or others. The prohibitions are stipulated in the Information Disclosure Policy 190
RkJQdWJsaXNoZXIy ODEyMzQ3